CASP3 and neoplasm: Immunohistochemistry analyses of tumor cell proliferation (Ki-67) and apoptosis (cleaved caspase 3, CC3) showed a reduction in proliferating cells (Figure 7C,E) along with higher cleaved caspase 3 rates in all of the treatment groups (Figure 7C,F).